JPH09509174A - ミコフェノール酸の５−置換誘導体 - Google Patents
ミコフェノール酸の５−置換誘導体Info
- Publication number
- JPH09509174A JPH09509174A JP7521868A JP52186895A JPH09509174A JP H09509174 A JPH09509174 A JP H09509174A JP 7521868 A JP7521868 A JP 7521868A JP 52186895 A JP52186895 A JP 52186895A JP H09509174 A JPH09509174 A JP H09509174A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- methyl
- compound
- methoxy
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/198,749 US5493030A (en) | 1994-02-18 | 1994-02-18 | 5-substituted derivatives of mycophenolic acid |
| US08/198,749 | 1994-02-18 | ||
| PCT/US1995/001787 WO1995022538A1 (en) | 1994-02-18 | 1995-02-16 | 5-substituted derivatives of mycophenolic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH09509174A true JPH09509174A (ja) | 1997-09-16 |
Family
ID=22734662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7521868A Ceased JPH09509174A (ja) | 1994-02-18 | 1995-02-16 | ミコフェノール酸の５−置換誘導体 |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US5493030A (es) |
| EP (1) | EP0745073B1 (es) |
| JP (1) | JPH09509174A (es) |
| CN (1) | CN1141038A (es) |
| AT (1) | ATE194608T1 (es) |
| AU (1) | AU1875495A (es) |
| BR (1) | BR9506819A (es) |
| CA (1) | CA2183530A1 (es) |
| CO (1) | CO4340734A1 (es) |
| DE (1) | DE69517957T2 (es) |
| DK (1) | DK0745073T3 (es) |
| ES (1) | ES2149971T3 (es) |
| FI (1) | FI963218A7 (es) |
| GR (1) | GR3033864T3 (es) |
| GT (1) | GT199500007A (es) |
| HR (1) | HRP950070B1 (es) |
| IL (2) | IL112665A (es) |
| IS (1) | IS4264A (es) |
| MX (1) | MX9603478A (es) |
| MY (1) | MY112804A (es) |
| PE (1) | PE22996A1 (es) |
| PH (1) | PH31441A (es) |
| PT (1) | PT745073E (es) |
| SI (1) | SI0745073T1 (es) |
| SV (1) | SV1995000007A (es) |
| TW (1) | TW384288B (es) |
| UY (2) | UY23910A1 (es) |
| WO (1) | WO1995022538A1 (es) |
| ZA (1) | ZA951299B (es) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6514979B1 (en) | 1999-03-03 | 2003-02-04 | University Of Maryland Biotechnology Institute | Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor |
| US6811998B2 (en) | 1999-06-25 | 2004-11-02 | Roche Diagnostics Operations, Inc. | Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase |
| US7214754B2 (en) * | 1999-12-13 | 2007-05-08 | Ppg Industries Ohio, Inc. | Polymerizable polyol (allyl carbonate) compositions |
| US7179791B2 (en) | 2001-01-11 | 2007-02-20 | Duke University | Inhibiting GS-FDH to modulate NO bioactivity |
| WO2004012746A2 (en) * | 2002-08-02 | 2004-02-12 | The Regents Of The University Of California | New uses for inhibitors of inosine monophosphate dehydrogenase |
| WO2004096285A2 (en) * | 2003-04-25 | 2004-11-11 | Gilead Sciences, Inc. | Anti-infective phosphonate conjugates |
| EP1620109A2 (en) | 2003-04-25 | 2006-02-01 | Gilead Sciences, Inc. | Kinase inhibitor phosphonate conjugates |
| SG182849A1 (en) * | 2003-04-25 | 2012-08-30 | Gilead Sciences Inc | Antiviral phosphonate analogs |
| US7407965B2 (en) * | 2003-04-25 | 2008-08-05 | Gilead Sciences, Inc. | Phosphonate analogs for treating metabolic diseases |
| US20050261237A1 (en) * | 2003-04-25 | 2005-11-24 | Boojamra Constantine G | Nucleoside phosphonate analogs |
| US7432261B2 (en) * | 2003-04-25 | 2008-10-07 | Gilead Sciences, Inc. | Anti-inflammatory phosphonate compounds |
| CN101410120A (zh) * | 2003-04-25 | 2009-04-15 | 吉里德科学公司 | 抗炎的膦酸酯化合物 |
| US7452901B2 (en) * | 2003-04-25 | 2008-11-18 | Gilead Sciences, Inc. | Anti-cancer phosphonate analogs |
| US7470724B2 (en) * | 2003-04-25 | 2008-12-30 | Gilead Sciences, Inc. | Phosphonate compounds having immuno-modulatory activity |
| WO2005002626A2 (en) | 2003-04-25 | 2005-01-13 | Gilead Sciences, Inc. | Therapeutic phosphonate compounds |
| US20090247488A1 (en) * | 2003-04-25 | 2009-10-01 | Carina Cannizzaro | Anti-inflammatory phosphonate compounds |
| US7427636B2 (en) * | 2003-04-25 | 2008-09-23 | Gilead Sciences, Inc. | Inosine monophosphate dehydrogenase inhibitory phosphonate compounds |
| US20050187170A1 (en) * | 2003-06-16 | 2005-08-25 | Biocryst Pharmaceuticals, Inc. | Enhancing the efficiency of RNA polymerase inhibitors by using inosine monophosphate dehydrogenase inhibitors |
| DE602004015310D1 (de) * | 2003-09-11 | 2008-09-04 | Sandoz Ag | Verfahren zur herstellung von mycophenolatmofetil |
| US7432273B2 (en) * | 2003-10-24 | 2008-10-07 | Gilead Sciences, Inc. | Phosphonate analogs of antimetabolites |
| WO2005044279A1 (en) * | 2003-10-24 | 2005-05-19 | Gilead Sciences, Inc. | Purine nucleoside phosphonate conjugates |
| US20050153990A1 (en) * | 2003-12-22 | 2005-07-14 | Watkins William J. | Phosphonate substituted kinase inhibitors |
| BRPI0418031A (pt) * | 2003-12-22 | 2007-04-17 | Gilead Sciences Inc | inibidores de quinase fosfonato-substituìdos |
| BRPI0417988A (pt) * | 2003-12-22 | 2007-04-27 | Gilead Sciences Inc | análogos de fosfonato antivirais |
| EP1768662A2 (en) | 2004-06-24 | 2007-04-04 | Novartis Vaccines and Diagnostics, Inc. | Small molecule immunopotentiators and assays for their detection |
| PT2258376T (pt) | 2004-07-27 | 2019-05-31 | Gilead Sciences Inc | Análogos fosfonatados de compostos inibidores do vih |
| EP1809277A2 (en) * | 2004-10-26 | 2007-07-25 | Inc. Gilead Sciences | Phosphonate derivatives of mycophenolic acid |
| US20080161324A1 (en) * | 2006-09-14 | 2008-07-03 | Johansen Lisa M | Compositions and methods for treatment of viral diseases |
| CN101422424B (zh) * | 2007-10-31 | 2012-10-24 | 王世亮 | 霉酚酸类药物植入剂及其制备方法和应用 |
| BRPI0915878A2 (pt) | 2008-07-08 | 2015-11-03 | Gilead Sciences Inc | sais ou hidratos de compostos inibidores de hiv, seu uso e composição farmacêutica que os compreende |
| US9492426B2 (en) * | 2011-09-21 | 2016-11-15 | The Texas A&M University System | Mycophenolic acid analogues as anti-tumor chemosensitizing agents |
| CN105271935B (zh) * | 2015-11-03 | 2017-06-30 | 陶祖岐 | 一种生活垃圾制成的装饰板和包装箱板 |
| US12011429B2 (en) | 2016-06-02 | 2024-06-18 | Steven Baranowitz | Prevention and treatment of viral infections |
| US10603299B2 (en) | 2016-06-02 | 2020-03-31 | Steven Baranowitz | Prevention and treatment of viral infections |
| WO2017210262A1 (en) | 2016-06-02 | 2017-12-07 | Steven Baranowitz | Prevention and treatment of viral infections |
| PT3661937T (pt) | 2017-08-01 | 2021-09-24 | Gilead Sciences Inc | Formas cristalinas de ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-il)-4-fluoro-2,5-dihidrofurano-2-il)oxi)metil)(fenoxi)fosforil)-l-alaninato de etil (gs-9131) para tratamento de infeções virais |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5542995B2 (es) * | 1972-02-24 | 1980-11-04 | ||
| US3825571A (en) * | 1971-07-31 | 1974-07-23 | Chugai Pharmaceutical Co Ltd | Mycophenolic acid derivatives |
| JPS5529994B2 (es) * | 1972-03-02 | 1980-08-07 | ||
| US4515956A (en) * | 1982-12-16 | 1985-05-07 | The Dow Chemical Company | Selective preparation of isomers and enantiomers of cyclopropane carboxylic acids |
| US4479005A (en) * | 1982-12-16 | 1984-10-23 | The Dow Chemical Company | Selective preparation of isomers and enantiomers of cyclopropane carboxylic acids |
| US4686234A (en) * | 1985-11-27 | 1987-08-11 | Syntex (U.S.A) Inc. | Mycophenolic acid derivatives in the treatment of inflammatory diseases, in particular rheumatoid arthritis |
| US4959387A (en) * | 1986-01-23 | 1990-09-25 | Syntex (U.S.A.) Inc. | Mycophenolic acid derivatives in the treatment of rheumatoid arthritis |
| US4725622A (en) * | 1986-01-23 | 1988-02-16 | Syntex (U.S.A.) Inc. | Mycophenolic acid derivatives in the treatment of rheumatoid arthritis |
| US5231179A (en) * | 1986-01-27 | 1993-07-27 | Sumitomo Pharmaceuticals Company, Limited | Heterocyclic compounds and their production |
| US4748173A (en) * | 1987-01-30 | 1988-05-31 | Syntex (U.S.A.) Inc. | Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions |
| US4753935A (en) * | 1987-01-30 | 1988-06-28 | Syntex (U.S.A.) Inc. | Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions |
| US4861776A (en) * | 1987-01-30 | 1989-08-29 | Syntex (U.S.A) Inc. | Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof, compositions and use |
| US4727069A (en) * | 1987-01-30 | 1988-02-23 | Syntex (U.S.A.) Inc. | Heterocyclic aminoalkyl esters of mycophenolic acid, derivatives thereof and pharmaceutical compositions |
| JPH0637486B2 (ja) * | 1988-05-18 | 1994-05-18 | 三共株式会社 | 新規抗生物質フタレキシンおよびその製造法 |
| US4940797A (en) * | 1989-03-23 | 1990-07-10 | Merck & Co., Inc. | Process for synthesis of FK-506 C10-C18 intermediates |
| US5155228A (en) * | 1989-03-23 | 1992-10-13 | Merck & Co., Inc. | FK-506 C10-C18 process intermediates |
| US5068345A (en) * | 1989-10-30 | 1991-11-26 | Eastman Kodak Company | Oxazolidinone aldol adduct |
| US5247083A (en) * | 1992-07-10 | 1993-09-21 | Syntex (U.S.A.) Inc. | Direct esterification of mycophenolic acid |
-
1994
- 1994-02-18 US US08/198,749 patent/US5493030A/en not_active Expired - Lifetime
-
1995
- 1995-02-15 PH PH49980A patent/PH31441A/en unknown
- 1995-02-16 AT AT95910984T patent/ATE194608T1/de not_active IP Right Cessation
- 1995-02-16 IL IL11266595A patent/IL112665A/xx not_active IP Right Cessation
- 1995-02-16 MY MYPI95000420A patent/MY112804A/en unknown
- 1995-02-16 WO PCT/US1995/001787 patent/WO1995022538A1/en not_active Ceased
- 1995-02-16 CO CO95005930A patent/CO4340734A1/es unknown
- 1995-02-16 IL IL12413995A patent/IL124139A/xx not_active IP Right Cessation
- 1995-02-16 ZA ZA951299A patent/ZA951299B/xx unknown
- 1995-02-16 SI SI9530434T patent/SI0745073T1/xx unknown
- 1995-02-16 TW TW084101398A patent/TW384288B/zh not_active IP Right Cessation
- 1995-02-16 CN CN95191654A patent/CN1141038A/zh active Pending
- 1995-02-16 HR HR08/198,749 patent/HRP950070B1/xx not_active IP Right Cessation
- 1995-02-16 FI FI963218A patent/FI963218A7/fi unknown
- 1995-02-16 DK DK95910984T patent/DK0745073T3/da active
- 1995-02-16 ES ES95910984T patent/ES2149971T3/es not_active Expired - Lifetime
- 1995-02-16 DE DE69517957T patent/DE69517957T2/de not_active Expired - Fee Related
- 1995-02-16 PE PE1995262077A patent/PE22996A1/es not_active Application Discontinuation
- 1995-02-16 SV SV1995000007A patent/SV1995000007A/es not_active Application Discontinuation
- 1995-02-16 PT PT95910984T patent/PT745073E/pt unknown
- 1995-02-16 IS IS4264A patent/IS4264A/is unknown
- 1995-02-16 MX MX9603478A patent/MX9603478A/es unknown
- 1995-02-16 UY UY23910A patent/UY23910A1/es not_active IP Right Cessation
- 1995-02-16 EP EP95910984A patent/EP0745073B1/en not_active Expired - Lifetime
- 1995-02-16 BR BR9506819A patent/BR9506819A/pt active Search and Examination
- 1995-02-16 CA CA002183530A patent/CA2183530A1/en not_active Abandoned
- 1995-02-16 JP JP7521868A patent/JPH09509174A/ja not_active Ceased
- 1995-02-16 AU AU18754/95A patent/AU1875495A/en not_active Abandoned
- 1995-02-17 GT GT199500007A patent/GT199500007A/es unknown
- 1995-06-06 US US08/483,042 patent/US5633279A/en not_active Expired - Lifetime
-
1998
- 1998-11-23 UY UY25262A patent/UY25262A1/es not_active Application Discontinuation
-
2000
- 2000-07-13 GR GR20000401101T patent/GR3033864T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0745073B1 (en) | 5-substituted derivatives of mycophenolic acid | |
| JPH09509172A (ja) | 免疫抑制活性を有する６−置換ミコフェノール酸および誘導体 | |
| US5972936A (en) | Benzofuran carboxamides and their therapeutic use | |
| JPH09509171A (ja) | 免疫抑制活性を有するミコフェノール酸の４−アミノ誘導体 | |
| FR2481703A1 (fr) | Acides aminocyclopentane-alcenoiques et leurs esters, leur preparation et utilisation dans des compositions pharmaceutiques | |
| JP2003516400A (ja) | ヒドロキシルスチルベンならびに新規スチルベン誘導体および類似体による抗炎症治療および乾癬治療ならびにプロテインキナーゼ阻害 | |
| HU198474B (en) | Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same | |
| JP2002515879A (ja) | ５―置換及び５，５―二置換―３，４―ジヒドロキシ―２（５ｈ）―フラノン及びその使用法 | |
| JPH02188571A (ja) | 化合物 | |
| JPH09509170A (ja) | 免疫抑制活性を有する４−アミノ−６−置換ミコフェノール酸および誘導体 | |
| JPH09509173A (ja) | ５−置換ミコフェノール酸の４−アミノ誘導体 | |
| FR2621587A1 (fr) | Derives du dimethyl-2,2 chromene, procede pour leur preparation et composition pharmaceutiques les contenant | |
| JPH06503083A (ja) | ベンゾフラン及びベンゾチオフェン誘導体 | |
| EP0463944B1 (fr) | Acyl benzoxazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
| HK1012634B (en) | 6-substituted mycophenolic and derivatives with immunosuppressive activity | |
| HK1010784B (en) | 4-amino derivatives of 5-substituted mycophenolic acid | |
| JPH03170476A (ja) | 抗炎症フラノン誘導体およびその用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050412 |
|
| A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20050822 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050927 |